[go: up one dir, main page]

ES2134267T3 - 1alfa,24(s)-dihidroxi vitamina d2, su preparacion y utilizacion. - Google Patents

1alfa,24(s)-dihidroxi vitamina d2, su preparacion y utilizacion.

Info

Publication number
ES2134267T3
ES2134267T3 ES93921243T ES93921243T ES2134267T3 ES 2134267 T3 ES2134267 T3 ES 2134267T3 ES 93921243 T ES93921243 T ES 93921243T ES 93921243 T ES93921243 T ES 93921243T ES 2134267 T3 ES2134267 T3 ES 2134267T3
Authority
ES
Spain
Prior art keywords
vitamin
alpha
converted
preparation
dihidroxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93921243T
Other languages
English (en)
Inventor
Charles W Bishop
Ronald L Horst
Glenville Jones
Nicholas J Koszewski
Joyce C Knutson
Robert M Moriarty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bone Care International Inc
Original Assignee
Bone Care International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bone Care International Inc filed Critical Bone Care International Inc
Application granted granted Critical
Publication of ES2134267T3 publication Critical patent/ES2134267T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)

Abstract

SE DESCRIBE UNA VITAMINA D2 1 ,24(S)-DIHIDROXI UTIL COMO COMPONENTE ACTIVO EN COMPOSICIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE DESORDENES EN EL METABOLISMO DE CALCIO Y DE LA PIEL. LA INVENCION TAMBIEN INCLUYE LA PREPARACION DE VITAMINA D2 1 ,24(S)-DIHIDROXI SINTETICA PARTIENDO DE ERGOSTEROL QUE SE CONVIERTE MEDIANTE 6 PASOS EN 24-HIDROXIERGOSTEROL. ESTE ULTIMO ES IRRADIADO Y CONVERTIDO TERMICAMENTE EN VITAMINA D2 24-HIDROXI QUE SE CONVIERTE A SU VEZ MEDIANTE 6 PASOS EN VITAMINA D2 1 ,24(S)-DIHIDROXI. LA SINTESIS TAMBIEN PRODUCE NUEVOS INTERMEDIARIOS.
ES93921243T 1992-08-28 1993-08-30 1alfa,24(s)-dihidroxi vitamina d2, su preparacion y utilizacion. Expired - Lifetime ES2134267T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94024692A 1992-08-28 1992-08-28

Publications (1)

Publication Number Publication Date
ES2134267T3 true ES2134267T3 (es) 1999-10-01

Family

ID=25474483

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93921243T Expired - Lifetime ES2134267T3 (es) 1992-08-28 1993-08-30 1alfa,24(s)-dihidroxi vitamina d2, su preparacion y utilizacion.

Country Status (11)

Country Link
US (1) US6143910A (es)
EP (1) EP0614456B1 (es)
JP (1) JP3179495B2 (es)
AT (1) ATE181062T1 (es)
AU (2) AU4841193A (es)
CA (1) CA2121689C (es)
DE (1) DE69325253T2 (es)
DK (1) DK0614456T3 (es)
ES (1) ES2134267T3 (es)
GR (1) GR3030939T3 (es)
WO (1) WO1994005630A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
TWI247001B (en) * 1996-07-01 2006-01-11 Chugai Pharmaceutical Co Ltd The method for purifying vitamin d derivatives and its crystalline products
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
EP2340840B1 (en) * 1998-03-27 2012-08-29 Oregon Health Sciences University Pulse dose Vitamin D drug for the treatment of hyperproliferative skin diseases
US6362350B1 (en) 1999-07-01 2002-03-26 Wisconsin Alumni Research Foundation Crystalline 1α, 24(S)-dihydroxyvitamin D2 and method of purification thereof
IL153378A0 (en) * 2000-07-18 2003-07-06 Bone Care Internat Inc STABILIZED 1alpha-HYDROXY VITAMIN D
JP4451061B2 (ja) * 2000-10-27 2010-04-14 レオ ファーマ アクティーゼルスカブ 少なくとも１つのビタミンｄまたは１つのビタミンｄアナログおよび少なくとも１つのコルチコステロイドを含有する局所用組成物
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
CN101939009B (zh) * 2008-02-05 2013-07-17 哈博生物科学公司 药学固体形式

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670190A (en) * 1973-01-10 1987-06-02 Hesse Robert H 1-α-hydroxy vitamin D compounds and process for preparing same
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US4022891A (en) * 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
GB1583749A (en) * 1976-06-03 1981-02-04 Res Inst Medicine Chem Vitamin d derivatives
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4338250A (en) * 1981-04-27 1982-07-06 Wisconsin Alumni Research Foundation 1-Hydroxylation process
US4719205A (en) * 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
US4719204A (en) * 1984-03-05 1988-01-12 Wisconsin Alumni Research Foundation Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
DK0550702T3 (da) * 1991-01-08 1999-11-01 Bone Care Int Inc Fremgangsmåde til fremstilling og anvendelse af 1alfa,24-dihydroxy-vitamin D2

Also Published As

Publication number Publication date
GR3030939T3 (en) 1999-11-30
AU1486497A (en) 1997-05-22
DK0614456T3 (da) 1999-12-06
AU4841193A (en) 1994-03-29
EP0614456B1 (en) 1999-06-09
ATE181062T1 (de) 1999-06-15
DE69325253D1 (de) 1999-07-15
CA2121689A1 (en) 1994-03-17
US6143910A (en) 2000-11-07
CA2121689C (en) 2008-03-18
JP3179495B2 (ja) 2001-06-25
DE69325253T2 (de) 1999-12-02
WO1994005630A1 (en) 1994-03-17
EP0614456A4 (en) 1995-01-04
JPH07500848A (ja) 1995-01-26
EP0614456A1 (en) 1994-09-14

Similar Documents

Publication Publication Date Title
ES2134207T3 (es) Procedimiento de preparacion y de utilizacion de la vitamina 1alfa,24-dihidroxi vitamina d2.
ES2134267T3 (es) 1alfa,24(s)-dihidroxi vitamina d2, su preparacion y utilizacion.
NO921955L (no) Nye d-vitaminforbindelser og fremgangsmaate til fremstilling av samme
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
MX9203050A (es) Compuestos de analogos de triptamina.
AR019823A1 (es) Una composicion cosmetica para el cuidado de la piel y un metodo para reducir la irritacion o el picor de la piel
DE69313128D1 (de) Inhibitierung des haarwuchses
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
DE69315927D1 (de) Kosmetische Zusammensetzung, die einen Lipidstoff und eine Hydroxy - oder Ketofettsäure enthält
ATE177111T1 (de) Doppelbindungs-isomer von equilin erhalten durch säure-isomerisierung
WO1994005630B1 (en) 1α,24(S)-DIHYDROXY VITAMIN D2, ITS FORMATION AND USE
ATE193651T1 (de) Therapeutisches system zur behandlung der psoriasis
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
ES2074264T3 (es) Esteres de aminoacidos de la hidroquinona, su procedimiento de preparacion y composiciones farmaceuticas o cosmeticas que los contienen.
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
DE50202865D1 (de) Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
ES2140544T3 (es) Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas.
SE8107816L (sv) Medel for lokal behandling av paverkan fran seborre pa menniskans huvudsval
MX9204908A (es) Composiciones farmaceuticas para el tratamiento de transtornos de la piel.
MX9300244A (es) Derivados de difluorometilenandrostenona y proceso para su preparacion.
ES2100821A1 (es) Composicion de un producto tonico armonizador del cuerpo humano aplicable sobre la piel.
MX9709684A (es) Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel.
NO903956D0 (no) Sammensetninger som inneholder thymopentin til topisk behandling av hudsykdommer.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 614456

Country of ref document: ES